Good morning, everyone, and how are you today? We hope the all-too-short weekend was relaxing and enjoyable. Now, of course, the time has come to resume the usual routine of meetings and deadlines and what-not. And since the forecast calls for a hot day, we are fortifying ourselves with a hot cup of stimulation. Please join us. Meanwhile, here are some tidbits to help get the workweek under way. Hope all goes well and drop us a line if you hear something interesting...
Par Pharmaceutical To Be Acquired For $1.8B By TPG (Associated Press)
Glaxo To Buy Human Genome For $2.8 Billion (Reuters)
CVS Caremark PBM To Block More Drugs (Dow Jones)
Glaxo And Theravance File Advair Follow-Up (Pharma Times)
deCode CEO Discusses Alzheimer's Discovery (Bio-IT World)
India To Use Unique ID To Check Fake Medicines (Economic Times)
What To Expect From J&J Earnings (Associated Press)
Aurobindo And Other Drugmakers Cited For Polluting (Times of India)
Seattle Genetics CEO Not Interested In A Sale (Bloomberg News)
Watson Gets FDA OK To Sell Generic Morning After Pill (Pharma Times)
South Africa's Adcock-Ingram Buys India's Cosme Pharma (Business Standard)
EDITOR'S NOTE: Please check this post for updates during the day
steaming coffee pic thx to dleggett on flickr